JJ
Insider buying
Jennifer Jarrett bought $253K of Damora Therapeutics, Inc. (DMRA) stock
Jennifer Jarrett, Director, President and CEO of Damora Therapeutics, Inc. (DMRA), bought 12,500 shares of DMRA stock worth $253K, per an SEC Form 4 filed Sep 28, 2026.
It was an open-market purchase.
The trade happened on Sep 25, 2026, 3 days before it was made public.
DMRA has moved +0.0% since the trade date, from $20.66 to $20.66 (Sep 25, 2026 close).
- Traded
- Sep 25, 2026
- Disclosed
- Sep 28, 2026
- Filing delay
- 3 days
- Price since
- +0.0%
- Role
- Director, President and CEO
- Source
- SEC Form 4
More DMRA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.